Novo VP Weighs In on Approval of Lilly's Obesity PillBloomberg1 Apr 2026Duration: 5:33Read the full storyUp nextBloomberg Invest Dallas 2026 HighlightsTake-Two CEO Zelnick: AI Wont Kill Gaming JobsUBS' Laud Sees Underpriced Risk in AI's 'Web of Debt'COP31 Negotiations Open With Smaller GoalsCoreWeave Gives Bulls a Green Light: Market AnalysisAllianz CIO Says Markets Are Underestimating Inflation Surge
